No Data
No Data
No Data
No Data
No Data
Pillar Biosciences OncoReveal CDx Pan-cancer Solid Tumor IVD Now FDA Approved for General Tumor Profiling on the Illumina MiSeq Dx System
Company continues to execute on its global strategy to bring highly accurate and sensitive NGS cancer diagnostics to enable localized testingNATICK, Mass., April 23, 2024 /PRNewswire/ -- Pillar Biosc
PR NewswireApr 23 10:00 ET
Illumina (NASDAQ:ILMN) Investors Are Sitting on a Loss of 71% If They Invested Three Years Ago
Yahoo FinanceApr 23 07:38 ET
Express News | Illumina Inc : Bernstein Cuts Target Price to $129 From $150
Moomoo 24/7Apr 23 05:23 ET
Top High Growth Investment Ratio Stocks From Each Sector - GS
Seeking AlphaApr 22 16:25 ET
Illumina, Inc.'s (NASDAQ:ILMN) Share Price Not Quite Adding Up
Illumina, Inc.'s (NASDAQ:ILMN) price-to-sales (or "P/S") ratio of 4.2x may not look like an appealing investment opportunity when you consider close to half the companies in the Life Sciences industry
Simply Wall StApr 22 08:19 ET
Express News | Illumina Inc : HSBC Cuts Target Price to $130 From $140: HSBC Cuts Target Price to $130 From $140
Moomoo 24/7Apr 22 00:13 ET
No Data
No Data
Chen Kiat : Very informative